- Home
- PTCT vs NSIT Comparison
PTCT vs NSIT Comparison
Compare PTCT & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- NSIT
- Stock Information
- Founded
- PTCT 1998
- NSIT 1988
- Country
- PTCT United States
- NSIT United States
- Employees
- PTCT N/A
- NSIT N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- NSIT EDP Services
- Sector
- PTCT Health Care
- NSIT Technology
- Exchange
- PTCT Nasdaq
- NSIT Nasdaq
- Market Cap
- PTCT 5.3B
- NSIT 3.4B
- IPO Year
- PTCT 2013
- NSIT 1995
- Fundamental
- Price
- PTCT $71.75
- NSIT $91.51
- Analyst Decision
- PTCT Buy
- NSIT Buy
- Analyst Count
- PTCT 17
- NSIT 3
- Target Price
- PTCT $73.24
- NSIT $168.33
- AVG Volume (30 Days)
- PTCT 1.1M
- NSIT 447.0K
- Earning Date
- PTCT 11-04-2025
- NSIT 10-30-2025
- Dividend Yield
- PTCT N/A
- NSIT N/A
- EPS Growth
- PTCT N/A
- NSIT N/A
- EPS
- PTCT 8.94
- NSIT 4.21
- Revenue
- PTCT $1,779,150,000.00
- NSIT $8,271,548,000.00
- Revenue This Year
- PTCT $119.02
- NSIT N/A
- Revenue Next Year
- PTCT N/A
- NSIT $3.42
- P/E Ratio
- PTCT $8.03
- NSIT $21.69
- Revenue Growth
- PTCT 97.54
- NSIT N/A
- 52 Week Low
- PTCT $35.95
- NSIT $91.18
- 52 Week High
- PTCT $73.98
- NSIT $181.92
- Technical
- Relative Strength Index (RSI)
- PTCT 72.03
- NSIT 15.78
- Support Level
- PTCT $66.10
- NSIT $97.30
- Resistance Level
- PTCT $69.88
- NSIT $111.54
- Average True Range (ATR)
- PTCT 2.47
- NSIT 3.15
- MACD
- PTCT 0.05
- NSIT -1.02
- Stochastic Oscillator
- PTCT 72.70
- NSIT 1.71
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.